financetom
Business
financetom
/
Business
/
Vesey Street Capital Partners Announces Sale of Gastro MD
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vesey Street Capital Partners Announces Sale of Gastro MD
Oct 28, 2025 5:55 AM

NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Vesey Street Capital Partners (VSCP) completed the full exit of portfolio company, Gastro MD, to AGA, LLC, an affiliate of United Digestive. Under our ownership the company achieved significant growth and completed several key strategic initiatives including doubling the provider base, developing state of the art endoscopy centers, and the establishment of several new office locations.

"Our goal with Gastro MD was to build a best-in-class asset in the digestive health sector and we are thrilled with the outcome. Prioritizing clinical excellence and working with world class physicians is key to any successful investment in the physician practice space and building the business model that allowed Dr. Gupta and the providers at Gastro MD to thrive was critical to our success," said Mike Doyle, Managing Partner at VSCP. "The combination of the Vesey Street and Gastro MD teams has furthered our foundational goal of serving our communities with exception care.  I look forward to seeing the continued success of Gastro MD as part of the United Digestive partner practices.  Our common values and commitment to the patients we serve make for an exciting partnership," highlighted Gastro MD founder, Dr. Vishal Gupta.

This outcome reflects VSCP's goal to be the private equity partner of choice for lower middle-market healthcare services companies, while positioning Gastro MD towards an important and impactful future.

This transaction was the result of direct negotiations between the parties, and no investment banker was retained in connection with the transaction. McDermott Will & Schulte acted as VSCP's legal advisor.

ABOUT GASTRO MD

Formed in 2019, Gastro MD was founded by physicians and seasoned healthcare executives to bridge the gap between clinical and business excellence; our vision is to build a community of cutting-edge clinical practices that sets the standard in care delivery for digestive health. Gastro MD providers serve the greater Orlando and Tampa areas across five locations. For more information, please visit: www.gastro-md.com.

ABOUT VESEY STREET CAPITAL PARTNERS

Vesey Street Capital Partners (VSCP) is a private equity firm with substantial and differentiated expertise, specializing in buyouts of lower middle-market healthcare services businesses. VSCP invests on behalf of a wide array of Limited Partners, including asset management firms, family offices, pension funds, and other institutional investors. Since its inception, VSCP has consummated 44 transactions across 12 platform businesses and has deployed $1 billion of equity capital. For more information, please visit www.vscpllc.com.

Media Contact:

Tiffany Laing, Investor Relations

Vesey Street Capital Partners

412 W 15th Street

2nd Floor

New York, NY 10011

Email: [email protected] 

Phone: 646-847-2474

View original content to download multimedia:https://www.prnewswire.com/news-releases/vesey-street-capital-partners-announces-sale-of-gastro-md-302596312.html

SOURCE Vesey Street Capital Partners

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Russian car sales seen declining to 1.4 mln units in 2025
Russian car sales seen declining to 1.4 mln units in 2025
Jan 13, 2025
MOSCOW, Jan 13 (Reuters) - The Association of European Businesses said on Monday that car sales in Russia in 2025 would decline by 15% to 1.4 million units. In November 2024, the AEB predicted that car sales in Russia would reach more than 1.6 million units in 2024. ...
Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate
Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate
Jan 13, 2025
04:47 AM EST, 01/13/2025 (MT Newswires) -- Caribou Biosciences ( CRBU ) said Sunday it initiated the phase 1 trial evaluating its experimental therapy, CB-010, in patients with lupus nephritis and extrarenal lupus. Additionally, the company said it expects to report data from a study of CB-010 to treat certain large B cell lymphoma patients in the first half of...
Merus, Biohaven Partner to Develop Bispecific Therapies for Cancers
Merus, Biohaven Partner to Develop Bispecific Therapies for Cancers
Jan 13, 2025
04:49 AM EST, 01/13/2025 (MT Newswires) -- Merus (MRUS) and Biohaven ( BHVN ) said Sunday they are partnering to co-develop three bispecific therapies using Merus' Biclonics platform and Biohaven's ( BHVN ) technologies. Financial terms of the research collaboration and license agreement were not disclosed. The collaboration has the potential to significantly benefit patients across various cancer types through...
BP Azerbaijan says working to resume work of Shah Deniz platform as soon as possible
BP Azerbaijan says working to resume work of Shah Deniz platform as soon as possible
Jan 13, 2025
BAKU, Jan 13 (Reuters) - BP is working to resolve technical problems at the Shah Deniz Alfa (SDA) platform and hopes to resume normal operations as soon as possible, the company told Reuters on Monday. BP suspended work of the platform on Friday after detecting a technical issue at the subsea gas condensate export line between the platform and the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved